RE: i will24 Jul 2021 22:23
I agree WIP. Multitude of great posters including zylo and the others who can squash a Wombles short written not factually supported rants in a heartbeat, and lth shining the beacon from quite some time ago and being very transparent in their opinions via non litigious posts!!
I have my ideas about possible RNS reports and timelines, but that is my speculation, which are all positive.
I still keep looking at the RNS rollout by Novacyt going back to December 2019 and the pursuing sp rise with a couple of shakes. But the be all and end all was speculation was rewarded.
I hasten to mention theirs was on the prediction/hope of a covid gene test.
They then got approval from PHE. Then the sp did 'rather well!!
Sareums position at this moment in time is not just one product . With Sareuem we have years of testing way before Novacyts tests in the same field (appreciate other fields as well so that's another tick in the box) but it is potentially a treatment for covid sufferers, as the Australian medical authority said such a treatment would be a gamechanger, amongst some rather other fantastic ipr with no let up in private investment.
Theirs was a potential test that got approved, ours is a potential treatment that has ticked many boxes.
I put it to fellow investors who discuss possible prices that a potential treatment as opposed to the initial Novacyt potential test would see Sareum as something worth a bit more than Novacyt? That's my thinking.
Regards Steadydanny